These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 8787672)

  • 1. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.
    Wu J; Wilson J; He J; Xiang L; Schur PH; Mountz JD
    J Clin Invest; 1996 Sep; 98(5):1107-13. PubMed ID: 8787672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of fas ligand gene mutation in patients with systemic lupus erythematosus.
    Kojima T; Horiuchi T; Nishizaka H; Sawabe T; Higuchi M; Harashima SI; Yoshizawa S; Tsukamoto H; Nagasawa K; Niho Y
    Arthritis Rheum; 2000 Jan; 43(1):135-9. PubMed ID: 10643709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.
    Del-Rey M; Ruiz-Contreras J; Bosque A; Calleja S; Gomez-Rial J; Roldan E; Morales P; Serrano A; Anel A; Paz-Artal E; Allende LM
    Blood; 2006 Aug; 108(4):1306-12. PubMed ID: 16627752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of molecular mimicry and aberrant autoantigen expression is important for development of anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.
    Mihara S; Suzuki N; Takeba Y; Soejima K; Yamamoto S
    Clin Exp Immunol; 2002 Aug; 129(2):359-69. PubMed ID: 12165095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional promoter haplotypes of the human FAS gene are associated with the phenotype of SLE characterized by thrombocytopenia.
    Nolsøe RL; Kelly JA; Pociot F; Moser KL; Kristiansen OP; Mandrup-Poulsen T; Harley JB
    Genes Immun; 2005 Dec; 6(8):699-706. PubMed ID: 16163374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on Fas ligand expression in patients with systemic lupus erythematosus].
    Feng Y
    Hokkaido Igaku Zasshi; 1997 Jul; 72(4):443-55. PubMed ID: 9266252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients.
    Wu J; Metz C; Xu X; Abe R; Gibson AW; Edberg JC; Cooke J; Xie F; Cooper GS; Kimberly RP
    J Immunol; 2003 Jan; 170(1):132-8. PubMed ID: 12496392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib.
    Bi LL; Pan G; Atkinson TP; Zheng L; Dale JK; Makris C; Reddy V; McDonald JM; Siegel RM; Puck JM; Lenardo MJ; Straus SE
    BMC Med Genet; 2007 Jul; 8():41. PubMed ID: 17605793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.
    Suzuki N; Ichino M; Mihara S; Kaneko S; Sakane T
    Arthritis Rheum; 1998 Feb; 41(2):344-53. PubMed ID: 9485093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
    Takahashi T; Tanaka M; Brannan CI; Jenkins NA; Copeland NG; Suda T; Nagata S
    Cell; 1994 Mar; 76(6):969-76. PubMed ID: 7511063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model.
    Nagata S
    J Hum Genet; 1998; 43(1):2-8. PubMed ID: 9609991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The -844C/T polymorphism in the Fas ligand promoter associates with Taiwanese SLE.
    Chen JY; Wang CM; Ma CC; Chow YH; Luo SF
    Genes Immun; 2005 Mar; 6(2):123-8. PubMed ID: 15674374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of apoptosis-related microsatellite polymorphisms on chromosome 1q in Taiwanese systemic lupus erythematosus patients.
    Chen JY; Wang CM; Lu SC; Chou YH; Luo SF
    Clin Exp Immunol; 2006 Feb; 143(2):281-7. PubMed ID: 16412052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Abnormal Fas and Fas ligand expression of lymphocytes in patients with SLE].
    Suzuki N; Sakane T
    Nihon Rinsho; 1996 Jul; 54(7):1955-9. PubMed ID: 8741694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete mutation scan of the human Fas ligand gene: linkage studies in Type I diabetes mellitus families.
    Nolsøe RL; Kristiansen OP; Larsen ZM; Johannesen J; Pociot F; Mandrup-Poulsen T
    Diabetologia; 2002 Jan; 45(1):134-9. PubMed ID: 11845233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of Fas ligand on anti-DNA autoantibody secreting B lymphocytes in patients with systemic lupus erythematosus: "immune privilege"-like state of the autoreactive B cells.
    Nagafuchi H; Wakisaka S; Takeba Y; Takeno M; Sakane T; Suzuki N
    Clin Exp Rheumatol; 2002; 20(5):625-31. PubMed ID: 12412192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of Fas ligand gene in human non-Hodgkin lymphoma.
    Kim HS; Lee SH; Lee JW; Soung YH; Lee JH; Park JY; Cho YG; Kim CJ; Kim SY; Lee YS; Park WS; Kim SH; Lee JY; Yoo NJ
    APMIS; 2003 Apr; 111(4):490-6. PubMed ID: 12780524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of Fas and Fas-L mutations in patients with lymphoproliferative disorders associated with Sjögren's syndrome and type II mixed cryoglobulinemia.
    Bertolo F; De Vita S; Dolcetti R; Carbone A; Ferraccioli GF; Bartoli E; Boiocchi M
    Clin Exp Rheumatol; 1999; 17(3):339-42. PubMed ID: 10410268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane-bound Fas ligand only is essential for Fas-induced apoptosis.
    O' Reilly LA; Tai L; Lee L; Kruse EA; Grabow S; Fairlie WD; Haynes NM; Tarlinton DM; Zhang JG; Belz GT; Smyth MJ; Bouillet P; Robb L; Strasser A
    Nature; 2009 Oct; 461(7264):659-63. PubMed ID: 19794494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.